| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9226287 | Journal of Allergy and Clinical Immunology | 2005 | 7 Pages |
Abstract
In patients with acute, uncomplicated rhinosinusitis, MFNS 200 μg twice daily produced significant symptom improvements versus amoxicillin and placebo, without predisposing the patient to disease recurrence or bacterial infection.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Eli O. MD, Claus MD, PhD, Heribert MD,